Literature DB >> 11346654

Regulation of cell growth by redox-mediated extracellular proteolysis of platelet-derived growth factor receptor beta.

H Okuyama1, Y Shimahara, N Kawada, S Seki, D B Kristensen, K Yoshizato, N Uyama, Y Yamaoka.   

Abstract

Redox-regulated processes are important elements in various cellular functions. Reducing agents, such as N-acetyl-l-cysteine (NAC), are known to regulate signal transduction and cell growth through their radical scavenging action. However, recent studies have shown that reactive oxygen species are not always involved in ligand-stimulated intracellular signaling. Here, we report a novel mechanism by which NAC blocks platelet-derived growth factor (PDGF)-induced signaling pathways in hepatic stellate cells, a fibrogenic player in the liver. Unlike in vascular smooth muscle cells, we found that reducing agents, including NAC, triggered extracellular proteolysis of PDGF receptor-beta, leading to desensitization of hepatic stellate cells toward PDGF-BB. This effect was mediated by secreted mature cathepsin B. In addition, type II transforming growth factor-beta receptor was also down-regulated. Furthermore, these events seemed to cause a dramatic improvement of rat liver fibrosis. These results indicated that redox processes impact the cell's response to growth factors by regulating the turnover of growth factor receptors and that "redox therapy" is promising for fibrosis-related disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11346654     DOI: 10.1074/jbc.M102995200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Angiotensin II stimulates phosphorylation of an ectodomain-truncated platelet-derived growth factor receptor-beta and its binding to class IA PI3K in vascular smooth muscle cells.

Authors:  Ben-Bo Gao; Hans Hansen; Hong-Chi Chen; Edward P Feener
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

2.  Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells.

Authors:  Tomohiro Ogawa; Norifumi Kawada; Kazuo Ikeda
Journal:  Hepatol Int       Date:  2009-04-21       Impact factor: 6.047

3.  Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis.

Authors:  Anna Moles; Núria Tarrats; Albert Morales; Marlene Domínguez; Ramón Bataller; Juan Caballería; Carmen García-Ruiz; José C Fernández-Checa; Montserrat Marí
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

4.  Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential.

Authors:  Anna Moles; Núria Tarrats; José C Fernández-Checa; Montserrat Marí
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

5.  Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.

Authors:  Jittima Weerachayaphorn; Yuhuan Luo; Albert Mennone; Carol J Soroka; Kathy Harry; James L Boyer
Journal:  J Hepatol       Date:  2013-08-23       Impact factor: 25.083

6.  Hepatic stellate cells' involvement in progenitor-mediated liver regeneration.

Authors:  Dana G Pintilie; Thomas D Shupe; Seh-hoon Oh; Susan V Salganik; Houda Darwiche; Bryon E Petersen
Journal:  Lab Invest       Date:  2010-05-03       Impact factor: 5.662

Review 7.  Matrix metalloproteinase gene delivery for liver fibrosis.

Authors:  Yuji Iimuro; David A Brenner
Journal:  Pharm Res       Date:  2007-06-19       Impact factor: 4.200

8.  Amino acids, L-Cysteine and L-Methionine, Attenuate Activation of Rat Stellate Cells in Primary Culture.

Authors:  Hiroko Matsui; Tokuko Takashima; Naoto Maeda; Yukihiro Imanishi; Naoki Uyama; Hiroaki Okuyama; Norifumi Kawada
Journal:  Comp Hepatol       Date:  2004-01-14

9.  Molecular mechanism of stellate cell activation and therapeutic strategy for liver fibrosis.

Authors:  Norifumi Kawada
Journal:  Comp Hepatol       Date:  2004-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.